LGND
Ligand Pharmaceuticals IncorporHealthcare$199.59
◆ Neutral
Mkt Cap: $3.98B|Float: 19.5M|SI: 7.5%|DTC: 7.2
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
41.3%
52W Range
$94-$228
ATR(14)
$8.93
Exp. Move
±12.4%
P/C Ratio
1.01
Earnings
May 7
GEX Negative
DEX Long
Net Call Premium
IV High
Exp. Move Wide
LGND Key Options Data
- IV Rank
- 100%
- Total GEX
- $-0.00B
- Total DEX
- $0.0M
- Max Pain
- $200.00
- Expected Move
- ±12.4%
- Put/Call OI
- 1.01
- Net Premium
- $0.1M
- Spot Price
- $199.59
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$24.85 | ±12.4% | $174.74 | $224.44 |
| 2026-05-15 | 43 | ±$31.05 | ±15.6% | $168.54 | $230.64 |
| 2026-08-21 | 141 | ±$23.00 | ±11.5% | $176.59 | $222.59 |
| 2026-11-20 | 232 | ±$53.50 | ±26.8% | $146.09 | $253.09 |
Explore LGND options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.